Immunovant (IMVT) PT Lowered to $28 at Stifel, Model Update Following Earnings
Tweet
Share
E-mailGet Alerts IMVT Hot Sheet
Price: $15.23 -1.23%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 20 | New: 68
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 20 | New: 68
Trade Now!
Join SI Premium – FREE
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Stifel analyst Derek C. Archila lowered the price target on Immunovant (NASDAQ: IMVT) to $28.00 (from $33.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Starbucks (SBUX) PT Raised to $135 at Oppenheimer Into Q1 Results (Earlier)
- United Rentals (URI) PT Raised to $375 at Stifel, Following Strategic Business Update
- Ambuja Cements Ltd. (ACEM:IN) PT Raised to INR380 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Stifel, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
